No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More News, features, and commentary about cancer-related issues Feb 09, 2024
Senators Thrash Pharma CEOs for Pricing Drugs Higher in the U.S. Sen. Bernie Sanders blamed "corrupt" system, well-paid lobbyists Feb 09, 2024
Mixed Results in Advanced Gastric/GEJ Cancer With Add-On Fruquintinib Significant improvement in PFS, but not OS, versus chemo alone in the second-line setting Feb 07, 2024
Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Risk Cessation at any age proved helpful for lowering cancer risk Feb 06, 2024
Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugs "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
King Charles' Health History; Supreme Court to Weigh COVID Misinfo; Toby Keith Dies Health news and commentary from around the Web gathered by MedPage Today staff Feb 06, 2024
Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patients Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
A Win for Trabectedin in High-Grade Myxoid Liposarcoma? Statistics support noninferiority versus more toxic chemotherapy, but results far from definitive Feb 02, 2024
Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Says Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
Sequential Therapy Boosts Survival in Metastatic Pancreatic Cancer Phase II study shows a 32% reduced risk of death compared with standard treatment Jan 31, 2024
Peripheral IV Access for Chemo Better Than Central Lines in Testicular Cancer? Retrospective study suggests the technique results in fewer complications, thrombotic events Jan 30, 2024
Unfavorable Colon Cancer Trends in Young Adults Seen Across the Pond, Too Rise in predicted CRC mortality among Europeans under 50 may be due to increasing obesity rates Jan 30, 2024
First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive Result Cabozantinib-pembrolizumab induced responses in 16 of 35 evaluable patients, but needed one more Jan 29, 2024
Science Sleuths Use Tech to Find Fakery and Plagiarism in Published Research These individuals are keeping researchers and science journals on their toes Jan 29, 2024
Adjuvant Pembrolizumab Boosts DFS in High-Risk Muscle Invasive Urothelial Cancer Benefit more than double with the immune checkpoint inhibitor compared with observation Jan 28, 2024
Cancer After Weight Loss; How Older Adults Use the Healthcare System Also in TTHealthWatch: PFAS guidelines for clinicians Jan 27, 2024 podcast
When a Revolutionary Cancer Treatment Causes Cancer The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
Native Hawaiian Physician-Scientist Kekoa Taparra Is Making Waves One of the first Native Hawaiians with an MD, PhD is tackling Pacific Islander health disparities Jan 23, 2024
New FDA Boxed Warning; College Shaken by Suicides; More Get Flu Shot Than COVID Vax Health news and commentary from around the Web gathered by MedPage Today staff Jan 23, 2024
Neoadjuvant PD-1 Blockade Boosts pCR Rates in Early Esophageal Cancer But will the benefit extend to event-free and overall survival? Jan 22, 2024
New Standard for Unresectable Hepatocellular Carcinoma? Adding durvalumab and bevacizumab to transarterial chemoembolization almost doubles PFS Jan 21, 2024
HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinoma One in three trial patients still alive at 3 years after hepatic arterial infusion pump treatment Jan 20, 2024
Radioligand Gets Big Win in High-Grade GEP Neuroendocrine Tumors Lutetium dotatate reduces PFS risk by 72% in randomized trial Jan 20, 2024
Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer But how much did investigational tiragolumab contribute to efficacy? Jan 19, 2024
Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer News, features, and commentary about cancer-related issues Jan 19, 2024
Long-Term Data Affirm First-Line Immunotherapy for Advanced Esophageal Cancer Three times as many patients alive at 5 years with chemo plus pembrolizumab Jan 19, 2024
Certain Cancer Survivors More Likely to Have Substance Use Disorder Prevalence particularly high in those recently diagnosed with head and neck and cervical cancers Jan 17, 2024
Cost of Genomic Testing on the Minds of Many Oncologists Insurance coverage, patient out-of-pocket costs key considerations for 80% of survey respondents Jan 16, 2024
Go Vegetarian to Avoid COVID? Making Dialysis Centers Work Better Also in TTHealthWatch: diagnostic errors among hospitalized patients Jan 13, 2024 podcast
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA News, features, and commentary about cancer-related issues Jan 12, 2024
COVID Vax and Blood Clots; Cancer Rise in Young Adults; Corpse-Abuse Charge Dropped Health news and commentary from around the Web gathered by MedPage Today staff Jan 12, 2024
Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivors While safe, the results do not support use of the drug in anthracycline-exposed survivors Jan 10, 2024
Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC T-cell response linked to 86% reduced risk of relapse, death Jan 09, 2024
Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestation Finding poses clinical and ethical dilemma for parents and clinicians Jan 08, 2024
Collaboration Between Local Oncologists and Academia Is Crucial Greater partnerships can optimize cancer care outcomes Jan 06, 2024
